| Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer? C Camps, R Sirera, R Bremnes, A Blasco, E Sancho, P Bayo, MJ Safont, ... Lung cancer 50 (3), 339-346, 2005 | 80 | 2005 |
| Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma P Bayo, A Jou, A Stenzinger, C Shao, M Gross, A Jensen, N Grabe, ... Molecular oncology 9 (8), 1704-1719, 2015 | 78 | 2015 |
| Glucocorticoid receptor is required for skin barrier competence P Bayo, A Sanchis, A Bravo, JL Cascallana, K Buder, J Tuckermann, ... Endocrinology 149 (3), 1377-1388, 2008 | 70 | 2008 |
| High S100A8 and S100A12 protein expression is a favorable prognostic factor for survival of oropharyngeal squamous cell carcinoma S Funk, R Mark, P Bayo, C Flechtenmacher, N Grabe, P Angel, ... International journal of cancer 136 (9), 2037-2046, 2015 | 44 | 2015 |
| Glucocorticoid receptor regulates overlapping and differential gene subsets in developing and adult skin LM Sevilla, P Bayo, V Latorre, A Sanchis, P Perez Molecular endocrinology 24 (11), 2166-2178, 2010 | 31 | 2010 |
| Identification of novel glucocorticoid receptor-regulated genes involved in epidermal homeostasis and hair follicle differentiation E Donet, P Bayo, E Calvo, F Labrie, P Pérez The Journal of Steroid Biochemistry and Molecular Biology 108 (1-2), 8-16, 2008 | 25 | 2008 |
| Regulation and function of Myb-binding protein 1A (MYBBP1A) in cellular senescence and pathogenesis of head and neck cancer B George, D Horn, P Bayo, K Zaoui, C Flechtenmacher, N Grabe, ... Cancer Letters 358 (2), 191-199, 2015 | 23 | 2015 |
| Transrepression function of the glucocorticoid receptor regulates eyelid development and keratinocyte proliferation but is not sufficient to prevent skin chronic inflammation E Donet, P Bosch, A Sanchis, P Bayo, A Ramírez, JL Cascallana, A Bravo, ... Molecular Endocrinology 22 (4), 799-812, 2008 | 17 | 2008 |
| Glucocorticoid receptor antagonizes EGFR function to regulate eyelid development. A Sanchis, P Bayo, LM Sevilla, P Pérez Universidad del País Vasco, 2010 | 13 | 2010 |
| Defective glucocorticoid receptor signaling and keratinocyte-autonomous defects contribute to skin phenotype of mouse embryos lacking the Hsp90 co-chaperone p23 M Madon-Simon, I Grad, P Bayo, P Pérez, D Picard PLoS One 12 (6), e0180035, 2017 | 10 | 2017 |
| Analysis of tumour-derived DNA in serum in advanced non-microcytic lung cancer: might it be a prognostic factor? CC Herrero, PB Zaera, RS Pérez, ES Salvador, AB Cordellat, ... Clinical and Translational Oncology 7, 122-126, 2005 | 4 | 2005 |
| The quantification of DNA in the serum is a useful prognostic factor in advanced non-small cell lung cancer (NSCLC) patients A Berrocal, R Sirera, C Camps, RM Bremnes, V Alberola, P Bayo, ... Journal of Clinical Oncology 23 (16_suppl), 7195-7195, 2005 | 1 | 2005 |
| Correlation of blood levels of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor and hemoglobin with response to therapy in advanced non-small cell … V Alberola, C Camps, R Sirera, RM Bremnes, P Bayo, A Blasco, ... Journal of Clinical Oncology 23 (16_suppl), 7228-7228, 2005 | | 2005 |
| Analysis of the clinical implications of c-kit expression in small cell lung cancer patients (SCLC) A Carrato, C Camps, R Sirera, MJ Safont, J Garde, P Bayo, A Berrocal, ... Journal of Clinical Oncology 23 (16_suppl), 7164-7164, 2005 | | 2005 |
| Clinical implications of c-Kit expression in smallcell lung cancer patients R Sirera, M Martin, MJ Safont, P Bayo, A Blasco, C Caballero, J Garde, ... LUNG CANCER 45, S38-S39, 2004 | | 2004 |
| Prognostic significance of K-ras point mutations in the serum of patients with advanced non-smallcell lung cancer R Sirera, P Bayo, M Martin, MJ Safont, A Blasco, C Caballero, J Garde, ... LUNG CANCER 45, S28-S28, 2004 | | 2004 |
| 277 Analysis of c-kit expression in small cell lung cancer patients and its clinical implications R Sirera, M Martin, P Bayo, A Blasco, MJ Safont, C Caballero, M Martorell, ... EJC Supplements 8 (2), 85, 2004 | | 2004 |
| P-471 Analysis of loss of heterozygosity LOH 9p21 (LOH) in serum DNA in advanced NSCLC and the relationship with response A Blasco, C Camps, E Sancho, A Berrocal, P Bayo, C Caballero, M Taron, ... Lung Cancer, S210, 2003 | | 2003 |
| P-284 Could be K-ras a prognostic factor in advanced NSCLC? Relationship with response to platinum based chemotherapy C Camps, A Blasco, A Berrocal, P Bayo, M Martín, M Tarón, J Sánchez, ... Lung Cancer, S164, 2003 | | 2003 |
| P-109 Evaluation of serum circulating tumor DNA in advanced non small cell lung cancer (NSCLC) and relationship with clinical and biological tumoral characteristics C Camps, A Blasco, E Sancho, A Berrocal, C Caballero, P Bayo, ... Lung Cancer, S118, 2003 | | 2003 |
Carlos CampsProfessor MedicineVerified email at gva.es
